639
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies

, &
Pages 18-26 | Received 20 Oct 2012, Accepted 17 Jan 2013, Published online: 18 Feb 2013

References

  • Arruebo M, Fernandez-Pacheco R, Ibarra MR, Santamaria J. 2007. Magnetic nanoparticles for drug delivery. Nanotoday. 2:22–32.
  • Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.
  • Brannon-Peppas L, Blanchette JO. 2004. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliver Rev. 56:1649–1659.
  • Chen D, Tang Q, Xue W, Xiang J, Zhang L, Wang X. 2010. The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles. J Biomed Res. 24:26–32.
  • Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. 2010. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 62:144–149.
  • Danhier F, Feron O, Preat V. 2010. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 148:135–146.
  • Dreis S, Rothweiler F, Michaelis M, Cinatl J Jr, Kreuter J, Langer K. 2007. Preparation, characterization and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharmaceut. 341:207–214.
  • Dsouza AJM, Topp EM. 2004. Release from polymeric prodrugs: linkages and their degradation. J Pharm SCI-US. 93:1962–1979.
  • Dung DKT, Hai TH, Phuc LH, Long DB, Vinh LK, Truc PN. 2009. Preparation and characterization of magnetic nanoparticles with chitosan coating. J Phys Conf Ser. 187:1–5.
  • Easo SL, Mohanan PV. 2013. Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydr Polym. 92:726–732.
  • Elsadek B, Kratz F. 2012. Impact of albumin on drug delivery – New applications on the horizon. J Control Release. 157:4–28.
  • Elzoghby AO, Samy WM, Elgindy NA. 2012. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 157:168–182.
  • Gaihre B, Aryal S, Khil MS, Kim HY. 2008. Encapsulation of Fe3O4 in gelatin nanoparticles: effect of different parameters on size and stability of the colloidal dispersion. J Microencapsul. 25:21–30.
  • Gaihre B, Khil MS, Lee DR, Kim HY. 2009. Gelatin coated magnetic iron oxide nanoparticles as carrier system: Drug loading and in vitro drug release study. Int J Pharmaceut. 365:180–189.
  • Gaumet M, Vargas A, Gurny R, Delie F. 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 69:1–9.
  • Jeong Y, Jin SG, Kim IY, Pei J, Wen M, Jung TY, et al. 2010. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B Biointerfaces. 79:149–155.
  • Jiang W, Yang HC, Yang SY, Horng HE, Hung JC, Chen YC, Hong CY. 2004. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J Magn Magn Mater. 283:210–214.
  • Kairemo K, Erba P, Bergström K, Pauwels EKJ. 2008. Nanoparticles in cancer. Curr Radiopharma. 1:30–36.
  • Kratz F. 2008. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release. 132:171–183.
  • Kumar C. 2006. Nanotechnologies for the life sciences: biological and pharmaceutical nanomaterials. In: Langer K, Ed. Peptide Nanoparticles, vol. 2. Weinheim: Wiley, pp. 145–184.
  • Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. 2003. Optimization of the preparation for human serum albumin (HSA) nanoparticles. Int J Pharmaceut. 257:169–180.
  • Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, et al. 2008. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharmaceut. 349: 274–282.
  • Li JM, Chen W, Wang H, Jin C, Yu XJ, Cui L, et al. 2009. Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacol Sin. 30: 1337–1343.
  • Merodio M, Arnedo A, Renedo MJ, Irache JM. 2001. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci. 12:251–259.
  • Min K, Jo H, Song K, Cho M, Chun YS, Jon S, et al. 2011. Dual-aptamer based delivery vehicle of doxorubicin to both PSMA(+) and PSMA(-) prostate cancers. Biomaterials. 32:2124–2132.
  • Moses MA, Brem H, Langer R. 2003. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell. 4:337–341.
  • Qu X, Yang C, Zhang J, Ding N, Lu Y, Huang L, Xiang G. 2010. In vitro evaluation of a Folate-bovine serum albumin- doxorubicin conjugate. J Drug Target. 18:351–361.
  • Reddy LH, Sharma RK, Murthy RSR. 2004. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate nanoparticles in mice bearing dalton's lymphoma tumour. J Drug Target. 12:443–451.
  • Shen Z, Wei W, Zhao Y, Ma G, Dobashi T, Maki Y, et al. 2008. Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. Eur J Pharmaceut Sci. 35:271–282.
  • Shen Z, Li Y, Kohama K, Oneill B, Bi J. 2011a. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res. 63:51–58.
  • Shen Z, Wei W, Tanaka H, Kohama K, Ma G, Dobashi T, et al. 2011b. A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. Pharmacol Res. 64:410–419.
  • Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics. CA Cancer J Clin. 62:10–29.
  • Singh R, Lillard JW. 2009. Nanoparticle based targeted drug delivery. Exp Mol Pathol. 86:215–223.
  • Sun J, Zhou S, Hou P, Yang Y, Weng J, Li X, Li M. 2006. Synthesis and characterization of biocompatible Fe3O4 nanoparticles. J Biomed Mater Res A. 80A:333–341.
  • Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. 2005. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech. 6:65–73.
  • Wagner S, Rothweiler F, Anhorn MG, Sauer D, Riemann I, Weiss EC, et al. 2010. Enhanced drug targeting by attachment of an anti αv integrin antibody to doxorubicin loaded human serum albumin nanoparticles. Biomaterials. 31:2388–2398.
  • Widder KJ, Senyei AE, Ranney DF. 1980. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Res. 40:3512–3517.
  • Yang X, Chen Y, Yuan R, Chen G, Blanco E, Gao J, Shuai X. 2008. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer. 49:3477–3485.
  • Zhang J, Misra RDK. 2007. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core–shell nanoparticle carrier and drug release response. Acta Biomaterialia. 3:838–850.
  • Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, Zhang Z. 2010. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed. 5:669–677.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.